Centre Hospitalier Regional De La Citadelle — Clinical Trial Site

128 Registered trials

64 Currently recruiting

Organisation

Centre Hospitalier Regional De La Citadelle

Location

Liege, Belgium

Identifier

ORG-100028257

Address

Boulevard Quatorzieme-De-Ligne 1, 4000, Belgium

Departments

-
102:Neurologie
1113: Oncology
354844, Centre de Référence des Maladies Neuromusculaires
446: Laboratoire
Anesthesiology
Cardiologie pédiatrique
Cardiology
Cardiovascular Department
Center for Reproductive Medicine
Centre de Réference des Maladies Neuromusculaires (CRMN)
Department Hématologie et oncologie pédiatrique
Department of Pediatric Hemato-Oncology
Department of Pediatric Nephrology
Gastro Enterology
gastro-entérologie, hépatologie et nutrition pédiatrique
Gastroenterology (Pediatric)
Gynécologie - Obstétrique
Haematology
Haematology Department
Hémato - oncologie pédiatrique
Hémato-Oncologie
Hématologie
Hematology
Hémotologie et oncologie pédiatrique
Intensive Care
Intensive Care Unit
Medial Oncology
Medical Oncology Department
N/A
Neonatology
Nephrology
Neuro paediatry
Neuro pediatry
Neurology
Oncology
Paediatric haemato oncology
Paediatric haemato-oncology
Paediatric Haematology and oncology
Paediatric neurology
Paediatrics
Pediatric gastroenterology
Pediatric hemato-oncology
Pediatric hemato-oncology department
Pediatric hematology and oncology
Pediatric neurology
Pediatric Rheumatology
Pediatrics
Physician
Pneumolgy
Pneumologie
Pneumologie - Allergologie
Pneumologie-Allergologie
Pneumology
Pneumology Department
Pulmonology
Reference Center for Neuromuscular Diseases (CRMN)
Rheumatology
Sleep Department
University Department of Neuropediatrics

Clinical trials at this site (128)

Search interface

Evaluation of the postoperative analgesic efficacy of erector spinae plane block in lumbar spinal surgery: a prospective randomized double-b… Recruiting

2023-504204-28-00 Patients undergoing lumbar arthrodesis 6 2023-10-17
A Study Evaluating the Overall Survival of Patients with Extensive Stage Small Cell Lung Cancer Receiving Trilaciclib or Placebo prior to To… Recruiting

2022-502357-34-00 Extensive Stage Small Cell Lung Cancer 5 2023-09-27
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML) Recruiting

2023-504999-25-00 Acute Myeloid Leukemia 5 2023-07-14
A Phase 2/3 Randomized, Placebo-Controlled, Double-blind, Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vericigua… Recruiting

2022-501238-52-00 Heart failure due to systemic left ventricular systolic 10 2023-03-23
Maintenance Pembrolizumab at Usual or Low doSE in non-squamous lung cancer: a non-inferiority study Recruiting

2023-503481-23-00 Maintenance treatment in metastatic non-squamous lung c 5 2023-03-20
WOEST-3 Recruiting

2022-502140-13-00 Atrial fibrillation Acute coronary syndrome Chronic cor 6 2023-01-11
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Patients With Stage III Unresectabl… Recruiting

2023-506891-28-00 The target population of interest in this study is part 5 2022-05-02
SIOP-HRMB: An international prospective trial on clinically high-risk medulloblastoma (HR-MB) in patients older than 3 years. Recruiting

2024-510578-25-00 Histologically proven high-risk medulloblastoma, with a 5 2021-11-05
Brain Injury and Ketamine: a prospective, randomized controlled double blind clinical trial to study the effects of ketamine on therapy inte… Recruiting

2023-505319-19-00 Traumatic brain injury 11 2021-09-01
Apremilast Study in Children with Active Juvenile Psoriatic Arthritis Recruiting

2023-503435-17-00 Juvenile psoriatic arthritis 5 2021-03-31
A clinical trial investigating the safety, tolerability, and therapeutic effects of BNT113 in combination with pembrolizumab versus pembroli… Recruiting

2024-512671-12-00 Unresectable head and neck squamous cell carcinoma, met 10 2021-03-05
FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma Recruiting

2024-510579-40-00 Rhabdoyosarcoma 9 2020-10-07
A study to assess the long-term safety and efficacy of a subcutaneous formulation of efgartigimod in adults with chronic inflammatory demyel… Recruiting

2023-507885-21-00 Chronic Inflammatory Demyelinating Polyneuropathy 4 2020-08-18
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
International study for children and adolescents with standard risk ALK-positive anaplastic large cell lymphoma (ALCL) estimating the effica… Recruiting

2022-501454-11-00 standard risk ALK-positive anaplastic large cell lympho 5 2020-02-05
SIOP RANDOMET 2017 Recruiting

2023-508926-91-00 Stage IV childhood renal tumour with pulmonary +/- non- 5 2019-12-05
LBL 2018 - International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma Recruiting

2023-508101-24-00 Lymphoblastic lymphoma 5 2019-08-01
Paediatric Hepatic International Tumour Trial Recruiting

2024-516110-38-00 Hepatoblastoma and Hepatocellular Carcinoma 5 2018-03-06
Study in which all the patients take the same investigational drug with the aim of evaluate the long-term safety, tolerability, and efficacy… Recruiting

2023-504520-26-00 Duchenne Muscular Dystrophy (DMD) 5 2017-10-19
SIOP Ependymoma II: An International Clinical Program for the diagnosis and treatment of children, adolescents and young adults with ependym… Recruiting

2024-512222-28-00 Newly diagnosed with an intracranial or spinal ependymo 10 2015-06-02
NOPHO-DBH AML 2012 Protocol: Research study for treatment of children and adolescents with acute myeloid leukemia 0-18 years Recruiting

2024-518254-16-00 Acute Myeloid Leukemia (Pediatric 0-18 years) 5 2013-03-01
A Dose-Finding Study of Tebapivat to Assess Efficacy, and Safety in Participants With Sickle Cell Disease Ended

2024-519746-70-01 Sickle Cell Disease 4 2025-09-15
A study to assess the efficacy and safety of Empasiprubart versus IVIg in adults with Multifocal Motor Neuropathy Ended

2024-516473-72-00 Multifocal Motor Neuropathy 5 2025-07-31